-
Myriad Genetics to Present at 44th Annual J.P. Morgan Healthcare Conference
05 Jan 2026 21:15 GMT
… -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing … myriad.com. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Zydus Lifesciences Limited signs an exclusive agreement with Myriad Genetics of US to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 09:31 GMT
… Agreement") with Myriad Genetics, a leader in molecular diagnostic testing and … oncology, this collaboration with Myriad Genetics will strengthen clinician education and … engage clinicians on three of Myriad Genetics' broadly validated diagnostic …
-
Zydus partners with Myriad Genetics to launch cancer-risk assessment diagnostic tests in India
19 Dec 2025 08:49 GMT
… an agreement with Myriad Genetics, a leader in molecular diagnostic testing and … oncology, this collaboration with Myriad Genetics will strengthen clinician education and … engage clinicians on three of Myriad Genetics’ broadly validated diagnostic platforms, …
-
Zydus Lifesciences signs exclusive agreement with Myriad Genetics to launch advanced cancer genomic tests in India
19 Dec 2025 04:46 GMT
… strategic agreement with Myriad Genetics, a global leader in molecular diagnostic testing and … market and promote three of Myriad Genetics’ diagnostic platforms in India: the …
-
Myriad Genetics to Present 8 Abstracts about MRD and Other Studies at 2025 San Antonio Breast Cancer Symposium
09 Dec 2025 14:00 GMT
… -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing … ):3468-3493 About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
25 Nov 2025 21:15 GMT
… a routine mammogram
Myriad Genetics – a leader in molecular diagnostic testing and … breast/. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences
11 Nov 2025 14:00 GMT
… -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing … myriad.com. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics Adds 15 Clinically Actionable Genes to MyRisk® Hereditary Cancer Test to Support Evolving Clinical Needs
10 Nov 2025 13:30 GMT
… ) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing … any way.
About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference
06 Nov 2025 13:30 GMT
… -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic … the conference. About Myriad Genetics
Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
-
Myriad Genetics Reports Third Quarter 2025 Financial Results; Reiterates 2025 Financial Guidance Following Continued Solid Execution
03 Nov 2025 21:05 GMT
… ) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing … myriad.com. About Myriad Genetics Myriad Genetics is a leading molecular diagnostic testing and … being for all. Myriad Genetics develops and offers molecular tests that help …
About
© 1995-2026